BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1704099)

  • 1. Decreased levels of guanyl nucleotide-binding regulatory protein alpha-subunits in Y1 adrenocortical tumor cell mutants resistant to forskolin.
    Schimmer BP; Tsao J
    Mol Endocrinol; 1990 Nov; 4(11):1698-703. PubMed ID: 1704099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective guanyl nucleotide-binding protein beta gamma subunits in a forskolin-resistant mutant of the Y1 adrenocortical cell line.
    Mitchell J; Northup JK; Schimmer BP
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8933-7. PubMed ID: 1409589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits.
    Qiu R; Tsao J; Kwan WK; Schimmer BP
    Mol Endocrinol; 1996 Dec; 10(12):1708-18. PubMed ID: 8961279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forskolin-resistant Y1 mutants harbor defects associated with the guanyl nucleotide-binding regulatory protein, Gs.
    Schimmer BP; Tsao J; Borenstein R; Endrenyi L
    J Biol Chem; 1987 Nov; 262(32):15521-6. PubMed ID: 2824464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin-resistant Y1 adrenal cell mutants are deficient in adenylyl cyclase type 4.
    Al-Hakim A; Rui X; Tsao J; Albert PR; Schimmer BP
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):155-65. PubMed ID: 15062554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of adenylyl cyclase-4 (AC-4) in Y1 and forskolin-resistant adrenal cells.
    Rui X; Al-Hakim A; Tsao J; Albert PR; Schimmer BP
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):101-8. PubMed ID: 15026181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered G protein activity in a desensitization-resistant mutant of the Y1 adrenocortical tumor cell line.
    Colantonio CM; Kwan WK; Czerwinski W; Mitchell J; Schimmer BP
    Endocrinology; 1998 Feb; 139(2):626-33. PubMed ID: 9449634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of G proteins in lacrimal gland.
    Meneray MA; Bennett DJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1173-80. PubMed ID: 7730026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanine nucleotide binding regulatory proteins and adenylate cyclase in livers of streptozotocin- and BB/Wor-diabetic rats. Immunodetection of Gs and Gi with antisera prepared against synthetic peptides.
    Lynch CJ; Blackmore PF; Johnson EH; Wange RL; Krone PK; Exton JH
    J Clin Invest; 1989 Jun; 83(6):2050-62. PubMed ID: 2498395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the mutation to forskolin-resistance in Y1 adrenocortical tumor cells.
    Schimmer BP; Tsao J; Collie G; Wong M; Schulz P
    Endocr Res; 1984-1985; 10(3-4):365-86. PubMed ID: 6100248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation.
    Yamamoto J; Ohyanagi M; Morita M; Iwasaki T
    J Mol Cell Cardiol; 1994 May; 26(5):617-26. PubMed ID: 8072016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Gi and Gq/11 in mediating desensitization of the luteinizing hormone/choriogonadotropin receptor in porcine ovarian follicular membranes.
    Rajagopalan-Gupta RM; Mukherjee S; Zhu X; Ho YK; Hamm H; Birnbaumer M; Birnbaumer L; Hunzicker-Dunn M
    Endocrinology; 1999 Apr; 140(4):1612-21. PubMed ID: 10098495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory guanine nucleotide binding protein in pig epidermis: transient increase of the 45KDA cholera toxin substrate (Gs alpha) in the tape stripping-induced hyperproliferative state.
    Tsutsui M; Tamura T; Takahashi H; Hashimoto Y; Iizuka H
    Epithelial Cell Biol; 1994; 3(4):161-7. PubMed ID: 7550608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma.
    Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
    Hepatology; 1997 Nov; 26(5):1189-94. PubMed ID: 9362361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor.
    Schimmer BP; Kwan WK; Tsao J; Qiu R
    J Cell Physiol; 1995 Apr; 163(1):164-71. PubMed ID: 7896893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for guanyl nucleotide-binding regulatory protein beta- and gamma-subunits in the expression of the adrenocorticotropin receptor.
    Qiu R; Frigeri C; Schimmer BP
    Mol Endocrinol; 1998 Dec; 12(12):1879-87. PubMed ID: 9849962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha.
    Berg JP; Sandvik JA; Ree AH; Sørnes G; Bjøro T; Torjesen PA; Gordeladze JO; Haug E
    Endocrinology; 1994 Aug; 135(2):595-602. PubMed ID: 8033808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and localization of G-proteins in the clonal adipocyte cell lines HGFu and Ob17.
    McFarlane-Anderson N; Cadrin M; Bégin-Heick N
    J Cell Biochem; 1993 Aug; 52(4):463-75. PubMed ID: 8227177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of thyroid hormone status on expression of genes encoding G protein subunits in the rat heart.
    Levine MA; Feldman AM; Robishaw JD; Ladenson PW; Ahn TG; Moroney JF; Smallwood PM
    J Biol Chem; 1990 Feb; 265(6):3553-60. PubMed ID: 1689305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.